Director, in vivo pharmacology

Rick Shin, Ph.D.

Rick joined atai Life Sciences in September 2021. Previously, Rick was the Director of Toxicology at Pacific BioLabs, where he was responsible for the oversight of all Toxicology GLP, cGMP, ISO, USP testing for biocompatibility, bioassay, toxin, and customized studies.

Prior to that, he was a Principal Scientist at Crinetics Pharmaceuticals and MD Anderson Cancer Center where he was responsible for all in vivo pharmacology and toxicology studies in endocrinology and neurodegeneration platforms.

Dr. Shin holds a Ph.D. and Master’s degree in Neuroscience from Carleton University (Canada), and a Bachelor’s degree in Neuroscience from the University of Toronto.

<<  Back to our team